Literature DB >> 9133423

PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors.

E W Scott1, R C Fisher, M C Olson, E W Kehrli, M C Simon, H Singh.   

Abstract

Transcription factor PU.1 is required for the development of lymphoid and myeloid progenitors during fetal hematopoiesis. By generating chimeric animals using PU.1-/- ES cells or PU.1(-/-) hematopoietic progenitors, we demonstrate that PU.1 functions in an exclusively cell-autonomous manner to regulate the development of the lymphoid-myeloid system. Multipotential lymphoid-myeloid progenitors (AA4.1+, Lin-) are significantly reduced in PU.1(-/-) embryos and fail to differentiate into B lymphoid or myeloid cells in vitro. These results suggest that the lymphoid and myeloid lineages develop in the fetal liver from a common hematopoietic progenitor not shared with erythrocytes and megakaryocytes. Finally, the Ikaros gene is expressed in PU.1 mutant embryos, suggesting that PU.1 and Ikaros are independently required for specification of embryonic lymphoid cell fates.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9133423     DOI: 10.1016/s1074-7613(00)80287-3

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  70 in total

1.  MafB is an inducer of monocytic differentiation.

Authors:  L M Kelly; U Englmeier; I Lafon; M H Sieweke; T Graf
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

Review 2.  Role of transcription factors C/EBPalpha and PU.1 in normal hematopoiesis and leukemia.

Authors:  Steffen Koschmieder; Frank Rosenbauer; Ulrich Steidl; Bronwyn M Owens; Daniel G Tenen
Journal:  Int J Hematol       Date:  2005-06       Impact factor: 2.490

3.  Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation.

Authors:  Hiromi Iwasaki; Chamorro Somoza; Hirokazu Shigematsu; Estelle A Duprez; Junko Iwasaki-Arai; Shin-Ichi Mizuno; Yojiro Arinobu; Kristin Geary; Pu Zhang; Tajhal Dayaram; Maris L Fenyus; Shannon Elf; Susan Chan; Philippe Kastner; Claudia S Huettner; Richard Murray; Daniel G Tenen; Koichi Akashi
Journal:  Blood       Date:  2005-05-24       Impact factor: 22.113

4.  Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia.

Authors:  Donald Metcalf; Aleksandar Dakic; Sandra Mifsud; Ladina Di Rago; Li Wu; Stephen Nutt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

5.  PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors.

Authors:  C Nerlov; T Graf
Journal:  Genes Dev       Date:  1998-08-01       Impact factor: 11.361

6.  Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.

Authors:  G H Su; H M Chen; N Muthusamy; L A Garrett-Sinha; D Baunoch; D G Tenen; M C Simon
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

7.  BCAP inhibits proliferation and differentiation of myeloid progenitors in the steady state and during demand situations.

Authors:  Jeffrey M Duggan; Matthew B Buechler; Rebecca M Olson; Tobias M Hohl; Jessica A Hamerman
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

8.  Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia.

Authors:  Iléana Antony-Debré; Vladimir T Manchev; Nathalie Balayn; Dominique Bluteau; Cécile Tomowiak; Céline Legrand; Thierry Langlois; Olivia Bawa; Lucie Tosca; Gérard Tachdjian; Bruno Leheup; Najet Debili; Isabelle Plo; Jason A Mills; Deborah L French; Mitchell J Weiss; Eric Solary; Remi Favier; William Vainchenker; Hana Raslova
Journal:  Blood       Date:  2014-12-09       Impact factor: 22.113

Review 9.  Transcriptional regulation of early B cell development.

Authors:  Daniel L Northrup; David Allman
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

10.  Erythropoietin down-regulates stem cell factor receptor (Kit) expression in the leukemic proerythroblast: role of Lyn kinase.

Authors:  Olivier Kosmider; Dorothée Buet; Isabelle Gallais; Nicole Denis; Françoise Moreau-Gachelin
Journal:  PLoS One       Date:  2009-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.